![Thomas Gad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Thomas Gad is the founder of Singad Pharma Aps, founded in 2003.
Mr. Gad was the founder of Y-mAbs Therapeutics, Inc., founded in 2015, holding the title of Vice Chairman & Chief Business Officer from 2023 to 2025.
Education includes an undergraduate degree from Pepperdine University.
Antiguos cargos conocidos de Thomas Gad.
| Empresas | Cargo | Fin |
|---|---|---|
| YMAS THER | Director Ejecutivo | 06/11/2023 |
Singad Pharma Aps | Fundador | 01/01/2013 |
Formación de Thomas Gad.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
27
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singad Pharma Aps | |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Gad
